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 The ‘Effects of Transfusion Thresholds on 
Neurocognitive Outcome of Extremely Low
Birth-Weight Infants (ETTNO)’ Study:
Background, Aims, and Study Protocol 
 ETTNO Investigators 1  
 
 Introduction 
 Infants with extremely low birth weight uniformly de-
velop anemia of prematurity and frequently require mul-
tiple red blood cell transfusions (RBCTs) during neonatal 
intensive care  [1–3] . The criteria currently applied to in-
dicate RBCTs in this population are based on expert 
opinion rather than evidence and there is a lack of con-
clusive data on long-term effects of RBCT practices. 
Transfusing infants to improve oxygen-carrying capacity 
and restricting RBCT to avoid transfusion-associated 
risks and costs may both potentially impair long-term de-
velopment.
 Potential Risks and Benefits of RBCTs 
 Although RBCTs are a universally accepted part of the 
treatment of preterm infants, recent reviews concluded 
that there are insufficient data on the long-term effects of 
RBCT practices  [4, 5] . In the absence of uniformly ac-
cepted physiologic or evidence-based RBCT criteria, 
RBCT practices vary greatly between neonatal intensive-
care units  [1, 6–10] .
 RBCTs may be associated with retinopathy of prema-
turity  [11–13] , bronchopulmonary dysplasia  [14, 15] , 
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acute pulmonary deteriorations  [16] , necrotizing entero-
colitis  [17–19] , intraventricular hemorrhage  [20] , and in-
creased mortality  [21] although these associations re-
quire cautious interpretation because of the retrospective 
and observational character of the underlying studies 
 [22] . RBCTs are also associated with a minute residual 
risk of transmission of infectious agents  [23] . Implement-
ing RBCT guidelines effectively reduces the number of 
RBCTs administered to preterm infants  [24, 25] , and ‘re-
strictive’ RBCT guidelines are feasible in very low birth-
weight infants and may result in very low numbers and 
low cumulative volumes of RBCTs  [26] .
 However, reducing RBCTs by accepting low hemoglo-
bin concentrations carries the risk of an at least tempo-
rarily insufficient oxygen transport to vital organs and 
impaired outcome  [27] .
 In a recent randomized trial of restrictive versus lib-
eral RBCT guidelines in 103 infants with birth weights of 
500–1,300 g, restrictive RBCT guidelines were associated 
with a marginally increased incidence of apnea  [28] . The 
study reported an increased incidence of brain injury (in-
traventricular hemorrhage grade 4 or periventricular leu-
komalacia) with restrictive RBCT guidelines. This study 
was criticized because (a) the primary endpoint for sam-
ple size determination was the number of transfusions 
and not a clinically relevant outcome parameter, (b) the 
combined outcome of intraventricular hemorrhage grade 
4 or periventricular leukomalacia had not been a pre-
defined outcome measure, (c) intraventricular hemor-
rhage usually occurs at a time when infants had not yet 
been enrolled into that study, (d) there was an excess of 
male patients in the restrictive-transfusion group and 
male infants tend to have poorer outcomes, (e) only 52% 
of the patients had a late cranial ultrasound, despite the 
latter being required to assess the true incidence of peri-
ventricular leukomalacia  [29–31] . In contrast to the ini-
tial findings, long-term follow-up showed poorer results 
in measures of associative verbal fluency, visual memory, 
and reading in the liberally transfused group  [32] and 
liberally transfused girls had the most prominent abnor-
malities on magnetic resonance imaging  [33] . Again, 
these latter results have to be interpreted with caution be-
cause only about half of the patients initially enrolled in 
the trial completed these follow-up examinations.
 In another recent randomized trial of restrictive ver-
sus liberal RBCT guidelines, the Premature Infant in 
Need of Transfusion (PINT) Trial, 451 infants with a 
birth weight  ! 1,000 g were enrolled. Restrictive RBCT 
guidelines were associated with fewer transfusions but 
there were no differences in the primary outcome, death 
or survival with retinopathy of prematurity  6 3rd degree, 
bronchopulmonary dysplasia, or brain injury on ultra-
sound  [34] . Nor was there a statistically significant differ-
ence in the incidence of death or severe adverse neurode-
velopmental outcome  [35] . However, post-hoc analyses 
showed that the proportion of infants with cognitive de-
lay defined as a Mental Developmental Index (MDI)  ! 85 
was lower and the mean MDI was higher in the liberal-
transfusion group, raising concern that restrictive trans-
fusion guidelines may result in impaired neurodevelop-
ment. Notably, maintaining higher hemoglobin concen-
trations appeared to be less costly  [36] .
 This study was criticized for the fact that the mean dif-
ference in hemoglobin levels between the two treatment 
groups was only marginal (1 g/dl) and that the mean he-
moglobin levels were high in both groups (10 vs. 11 g/dl) 
and may not reflect the range of RBCT guidelines cur-
rently proposed  [37] .
 Open Questions 
 There is insufficient evidence to decide whether pre-
term infants should be treated according to liberal or re-
strictive RBCT guidelines  [4 ,  5] . The long-term safety and 
efficacy of ‘restrictive’ RBCT practices can only be evalu-
ated in an adequately powered, large, randomized con-
trolled trial with long-term neurodevelopmental follow-
up and with a sufficient difference in mean hemoglobin 
levels between both treatment arms to reflect the range 
of RBCT guidelines currently applied. Such a trial may 
help to improve survival without neurodevelopmental 
impairment in preterm infants.
 Summary of Study  
 The Effects of Transfusion Thresholds on Neurocog-
nitive Outcome of Extremely Low Birth-Weight Infants 
(ETTNO) study is an observer-blinded randomized con-
trolled clinical trial. Nine hundred and twenty infants of 
400–999 g birth weight will be randomized to restrictive 
or liberal transfusion trigger thresholds between 48 and 
72 h of life, stratified by center and birth weight (400–
749 g/750–999 g) ( table 1 ). Sample size calculations were 
based on a   2 test assuming a power of 80%, a two-sided 
significance level of 5%, an incidence of death or major 
neurodevelopmental impairment (where cognitive delay 
is defined as MDI  ! 85) of 61% versus 51% in the restric-
tive-threshold and the liberal-threshold group, respec-
 The ETTNO Study Protocol  Neonatology 2012;101:301–305 303
tively, based on the reported outcome data of the PINT 
study  [35] .
 The assigned RBCT guidelines will be applied until 
discharge home from hospital. Both, the restrictive and 
the liberal RBCT guidelines to be compared in this trial 
reflect current clinical practice  [5, 6, 8, 26, 38–41] . These 
RBCT guidelines will result in a clinically relevant differ-
ence in mean hemoglobin concentrations between both 
treatment groups of about 2 g/dl and will therefore im-
prove recognition of any effect of transfusion trigger 
thresholds on neurocognitive outcome compared with 
the above referenced PINT trial  [34, 35] .
 The primary outcome, death or neurodevelopmental 
impairment, will be determined at 24 months of age, cor-
rected for prematurity. Funding for longer-term follow-
up until 5.5 years of age will be sought. Neurodevelop-
mental impairment will be defined as any of the follow-
ing: cognitive delay defined as MDI score of the  Bayley 
Scales of Infant Development (2nd edition)  ! 85, cerebral 
palsy, or severe visual or hearing impairment. In the in-
tention-to-treat population of all randomized patients in 
whom the primary outcome is ascertained, the primary 
outcome variable will be analyzed by logistic regression 
with factors treatment, center, and birth weight category 
at a two-sided significance level of 5%.
 The study has been approved by the leading ethics 
committee at the University of Tübingen, Germany, and 
by the German Regulatory Authority (Paul-Ehrlich-In-
stitut). Written informed consent will be required from 
parents or caretakers. 
 Recruitment began in August 2011 and units are in-
vited to participate. The results of ETTNO will provide 
definite data about the efficacy and safety of restrictive 
versus liberal RBCT guidelines in very preterm infants. 
 Collaborations will be sought with other groups to 
perform individual patient data meta-analyses to (a) ver-
ify the effect of different levels of transfusion trigger 
thresholds on neurodevelopmental outcome and (b) ana-
lyze the impact of transfusion triggers on less frequently 
observed complications of prematurity, such as severe 
retinopathy, severe chronic lung disease, necrotizing en-
terocolitis and others.
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Table 1.  ETTNO transfusion thresholds
Time after
randomization
Hematocrit, %
restrictive RBCT thresholds l iberal RBCT thresholds
critical noncritical crit ical noncritical
3–7 days of age <34 <28 <41 <35
8–21 days of age <30 <24 <37 <31
>21 days of age <27 <21 <34 <28
‘Critical’ refers to state of health and is defined as the presence of any of the following: (1) requirement of 
mechanical ventilation (any mode, excluding continuous positive airway pressure), (2) requirement of continu-
ous positive airway pressure with FiO2 >0.25 for >12 h per 24 h, (3) patent ductus arteriosus requiring therapy, 
(4) more than 6 apneas that require stimulation per 24 h, or more than 4 desaturations to SpO2 <60% per 24 h 
despite methylxanthines and continuous positive airway pressure and (5) acute sepsis or acute necrotizing en-
terocolitis requiring inotropic or vasopressor support.
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